Title

Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma
Angiotensin II Receptor Blockers, Steroids and Radiotherapy in Glioblastoma- A Randomized Multicenter Trial
  • Phase

    Phase 3
  • Study Type

    Interventional
  • Status

    Completed No Results Posted
  • Intervention/Treatment

    losartan ...
  • Study Participants

    80
To assess the efficacy of an Angiotensin-II inhibitor (Losartan) to reduce peritumoral edema in newly diagnosed glioblastoma patients.
Multicentre, randomized (1:1), double blinded trial:- Arm A: Standard of care (Radiotherapy with concomitant temozolomide followed by monthly cures of temozolomide ) + Losartan 50mg*2/day until the halting for any reason - Arm B: Standard of care (Radiotherapy with concomitant temozolomide followed by monthly cures of temozolomide + Placebo 2/day until the halting for any reason.
Study Started
Mar 29
2013
Primary Completion
Jan 15
2015
Study Completion
May 15
2017
Last Update
May 08
2020

Drug Losartan

Standard of care (Radiotherapy with concomitant temozolomide followed by monthly cures of temozolomide ) + Losartan or placebo (Arm A or B) 50mg*2/day until the halting for any reason

Drug Placebo

Standard of care (Radiotherapy with concomitant temozolomide followed by monthly cures of temozolomide + Placebo 2/day until the halting for any reason

Arm A: Losartan Active Comparator

Arm A: Standard of care (Radiotherapy with concomitant temozolomide followed by monthly cures of temozolomide ) + Losartan 50mg*2/day until the halting for any reason

Arm B: Placebo Placebo Comparator

Arm B: Standard of care (Radiotherapy with concomitant temozolomide followed by monthly cures of temozolomide + Placebo 2/day until the halting for any reason

Criteria

Inclusion Criteria:

18 years or older
Histologically confirmed glioblastoma (Grade 4 WHO)
patients eligible for radiotherapy and concomitant Temozolomide
KPS ≥ 50%
Adequate hematologic, liver and renal functions

Exclusion Criteria:

Patients unable to undergo an MRI with contrast
Patients without any residual tumor left on the screening MRI of both flair and contrast-enhanced lesions complete surgical resection)
Any prior treatment of glioblastoma including any local therapy (immunotherapy, Gliadel wafers, …..) during or after surgical resection
Any on-going treatment for high blood pressure at time of inclusion, whatever the therapeutic class of drugs
Systolic blood pressure <110 mmHg.
relative or definite contra-indication to Losartan:
Pregnant or breast feeding women; Women with an intact uterus (unless amenorrhoeic for the last 24 months) not using effective means of contraception
Non-affiliation to the "sécurité sociale"
No Results Posted